SciELO - Scientific Electronic Library Online

 
vol.29 número3Diabetes mellitus tipo 1 en una paciente con hepatitis c durante el tratamiento con interferón alfa. Primer caso comunicado en CubaCuantificación de ácido ribonucleico para la realización de la técnica de RT- PCR índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Cubana de Hematología, Inmunología y Hemoterapia

versión impresa ISSN 0864-0289

Resumen

SANCHEZ SEGURA, Miriam de la C et al. Progressive Hemifacial Atrophy or Parry Romberg Syndrome associated with immunodeficiency. Rev Cubana Hematol Inmunol Hemoter [online]. 2013, vol.29, n.3, pp.289-297. ISSN 0864-0289.

The progressive hemifacial atrophy (AHP) or Parry Romberg syndrome, is a rare degenerative disease, characterized by slowly progressive unilateral facial atrophy involving the subcutaneous tissue, cartilage, fat tissue and underlying bone structures, which often overlaps with a condition known as linear scleroderma «en coup of sabre». To our knowledge has not been reported the association between immunodeficiency and this syndrome. We report the case of a child of 5 years with AHP, with a history of recurrent infectious processes, some serious, since he was 7 months old. The immunological study showed T cell immunodeficiency, lymphocyte subpopulations showed T/CD4 T/CD3 + cells values decreased and normal value B/CD19 + cells. The presence of antinuclear homogeneous pattern and anti-dsDNA antibodies confirm de autoimmune disorders described in these patients. The cellular immunodeficiency with AHP is an expression of great clinical variability of this disease and the importance of early diagnosis.

Palabras clave : inmunodeficiencies; Parry Romberg syndrome; Progressive Hemifacial Athrophy.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons